Alström syndrome: Insights into the pathogenesis of metabolic disorders

Nature Reviews Endocrinology

Volumn 7, Issue 2, 2011, Pages 77-88

  Girard, Dorothée ^a   Petrovsky, Nikolai ^a  

^a FLINDERS UNIVERSITY   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

2,4 THIAZOLIDINEDIONE DERIVATIVE; ALMS1 PROTEIN; ESTROGEN PROGESTAGEN; EXENDIN 4; FIBRIC ACID DERIVATIVE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; LEVOTHYROXINE; MELANIN CONCENTRATING HORMONE RECEPTOR 1; MEMBRANE PROTEIN; METFORMIN; PROGESTERONE DERIVATIVE; RECOMBINANT GROWTH HORMONE; SEROTONIN 6 RECEPTOR; SOMATOMEDIN C; SOMATOSTATIN RECEPTOR 3; TESTOSTERONE; UNCLASSIFIED DRUG;

ACANTHOSIS NIGRICANS; ACUTE PANCREATITIS; ALSTROM SYNDROME; AUTOPSY; AUTOSOMAL RECESSIVE INHERITANCE; AUTOSOMAL RECESSIVE POLYCYSTIC KIDNEY DISEASE; BARDET BIEDL SYNDROME; BODY FAT; BRAIN MALFORMATION; CALORIC RESTRICTION; CARDIOMYOPATHY; CAUSE OF DEATH; CAVALLAZZI SYNDROME; CENTROSOME; CHROMOSOME 20P; CILIARY MOTILITY; COGNITIVE DEFECT; CONGENITAL MALFORMATION; CRANIOECTODERMAL DYSPLASIA; DEVELOPMENTAL DISORDER; DISEASE MODEL; EARLY DIAGNOSIS; ELLIS VAN CREVELD SYNDROME; ENDOCRINE DISEASE; EXON; FIBROSIS; FOLLOW UP; GENE EXPRESSION; GENE INSERTION; GENE LOCATION; GENE MAPPING; GENE MUTATION; GENETIC DISORDER; GENETIC IDENTIFICATION; GENETIC LINKAGE; GENETIC POLYMORPHISM; GLUCOSE INTOLERANCE; GLYCEMIC CONTROL; HEART DISEASE; HEART FAILURE; HEART LUNG TRANSPLANTATION; HEART MUSCLE FIBROSIS; HOMOZYGOSITY; HUMAN; HYPERANDROGENISM; HYPERINSULINEMIA; HYPERLEPTINEMIA; HYPERLIPIDEMIA; HYPOGONADISM; HYPOGONADOTROPIC HYPOGONADISM; HYPOTHYROIDISM; IMMUNOHISTOCHEMISTRY; INFERTILITY; INSULIN RESISTANCE; INTRACELLULAR TRANSPORT; JEUNE ASPHYXIATING THORACIC DYSTROPATHY SYNDROME; JOUBERT SYNDROME; KARTAGENER SYNDROME; KIDNEY FAILURE; KIDNEY FIBROSIS; KIDNEY TRANSPLANTATION; LEBER CONGENITAL AMAUROSIS; LIFE EXPECTANCY; LIVER DYSFUNCTION; LIVER FAILURE; LIVER FIBROSIS; LUNG DISEASE; MECKEL SYNDROME; MENSTRUATION DISORDER; METABOLIC DISORDER; MISSENSE MUTATION; MORBIDITY; NEPHRONOPHTHISIS; NON INSULIN DEPENDENT DIABETES MELLITUS; NONALCOHOLIC FATTY LIVER; NONHUMAN; OBESITY; OROFACIODIGITAL SYNDROME 1; OVARY FIBROSIS; OVARY POLYCYSTIC DISEASE; PANCREAS ISLET BETA CELL; PATHOGENESIS; PATIENT COUNSELING; PERCEPTION DEAFNESS; PHENOTYPE; POLYDACTYLY; PREVALENCE; PRIMARY CILIARY DYSKINESIA; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEOMICS; RETINITIS PIGMENTOSA; REVIEW; SEMINIFEROUS TUBULE; SENIOR LOKEN SYNDROME; SENSORY DYSFUNCTION; SHORT RIB POLYDACTYLY SYNDROME I-IV; SITUS INVERSUS; SKELETON MALFORMATION; TREATMENT INDICATION; UROGENITAL TRACT DISEASE; VISUAL DISORDER;

ALSTROM SYNDROME; ANIMALS; BARDET-BIEDL SYNDROME; DIABETES MELLITUS, TYPE 2; HUMANS; MUTATION; OBESITY; PROTEINS;

EID: 79451474853     PISSN: 17595029     EISSN: 17595037     Source Type: Journal    
DOI: 10.1038/nrendo.2010.210     Document Type: Review

References (128)

1. Adams, M., Smith, U. M., Logan, C. v. & Johnson, C. A. Recent advances in the molecular pathology, cell biology and genetics of ciliopathies. J. Med. Genet. 45, 257-267 (2008).
2. Cardenas-Rodriguez, M. & Badano, J. L. Ciliary biology: understanding the cellular and genetic basis of human ciliopathies. Am. J. Med. Genet. C Semin. Med. Genet. 151c, 263-280 (2009).
3. Muller, J. et al. Identification of 28 novel mutations in the Bardet-Biedl syndrome genes: the burden of private mutations in an extensively heterogeneous disease. Hum. Genet. 127, 583-593 (2010).
4. Hampshire, D. J. et al. MORM syndrome (mental retardation, truncal obesity, retinal dystrophy and micropenis), a new autosomal recessive disorder, links to 9q34. Eur. J. Hum. Genet. 14, 543-548 (2006).
5. Bielas, S. L. et al. Mutations in INPP5E, encoding inositol polyphosphate-5-phosphatase E, link phosphatidyl inositol signaling to the ciliopathies. Nat. Genet. 41, 1032-1036 (2009).
6. Jacoby, M. et al. INPP5E mutations cause primary cilium signaling defects, ciliary instability and ciliopathies in human and mouse. Nat. Genet. 41, 1027-1031 (2009).
7. Alstrom, C. H., Hallgren, B., Nilsson, L. B. & Asander, H. Retinal degeneration combined with obesity, diabetes mellitus and neurogenous deafness: a specific syndrome (not hitherto described) distinct from the Laurence-Moon-Bardet-Biedl syndrome: aclinical, endocrinological and genetic examination based on a large pedigree. Acta Psychiatr. Neurol. Scand. Suppl. 129, 1-35 (1959).
8. Badano, J. L., Mitsuma, N., Beales, P. L. & Katsanis, N. The ciliopathies: an emerging class of human genetic disorders. Annu. Rev. Genomics Hum. Genet. 7, 125-148 (2006).
9. Baker, K. & Beales, P. L. Making sense of cilia in disease: the human ciliopathies. Am. J. Med. Genet. C Semin. Med. Genet. 151c, 281-295 (2009).
10. Orphanet [online], http://www.orpha.net/ (2010).
11. Andersen, J. S. et al. Proteomic characterization of the human centrosome by protein correlation profiling. Nature 426, 570-574 (2003).
12. Hearn, T. et al. Mutation of ALMS1, a large gene with a tandem repeat encoding 47 amino acids, causes Alström syndrome. Nat. Genet. 31, 79-83 (2002).
13. Hearn, T. et al. Subcellular localization of ALMS1 supports involvement of centrosome and basal body dysfunction in the pathogenesis of obesity, insulin resistance, and type 2 diabetes. Diabetes 54, 1581-1587 (2005).
14. Adams, N. A., Awadein, A. & Toma, H. S. The retinal ciliopathies. Ophthalmic Genet. 28, 113-125 (2007).
15. Beales, P. L., Elcioglu, N., Woolf, A. S., Parker, D. & Flinter, F. A. New criteria for improved diagnosis of Bardet-Biedl syndrome: results of a population survey. J. Med. Genet. 36, 437-446 (1999).
16. Marshall, J. D., Beck, S., Maffei, P. & Naggert, J. K. Alström syndrome. Eur. J. Hum. Genet. 15, 1193-1202 (2007).
17. Marshall, J. D. et al. New Alström syndrome phenotypes based on the evaluation of 182 cases. Arch. Intern. Med. 165, 675-683 (2005).
18. Michaud, J. L. et al. Natural history of Alström syndrome in early childhood: onset with dilated cardiomyopathy. J. Pediatr. 128, 225-229 (1996).
19. Satman, I. et al. Evaluation of insulin resistant diabetes mellitus in Alström syndrome: a longterm prospective follow-up of three siblings. Diabetes Res. Clin. Pract. 56, 189-196 (2002).
20. Paisey, R. B., Hodge, D. & Williams, K. Body fat distribution, serum glucose, lipid and insulin response to meals in Alström syndrome. J. Hum. Nutr. Diet. 21, 268-274 (2008).
21. Minton, J. A. et al. Syndromic obesity and diabetes: changes in body composition with age and mutation analysis of ALMS1 in 12 United Kingdom kindreds with Alstrom syndrome. J. Clin. Endocrinol. Metab. 91, 3110-3116 (2006).
22. Paisey, R. B. et al. Hypertriglyceridaemia in Alströms syndrome: causes and associations in 37 cases. Clin. Endocrinol. 60, 228-231 (2004).
23. Wu, W.-C. et al. Alström syndrome with acute pancreatitis: a case report. Kaohsiung J. Med. Sci. 19, 358-361 (2003).
24. Awazu, M. et al. Hepatic dysfunction in two sibs with Alström syndrome: case report and review of the literature. Am. J. Med. Genet. 69, 13-16 (1997).
25. Connolly, M. B. et al. Hepatic dysfunction in Alström disease. Am. J. Med. Genet. 40, 421-424 (1991).
26. Poretsky, L., Cataldo, N. A., Rosenwaks, Z. & Giudice, L. C. The insulin-related ovarian regulatory system in health and disease. Endocr. Rev. 20, 535-582 (1999).
27. Dunaif, A. Insulin resistance and the polycystic ovary syndrome: mechanism and implications for pathogenesis. Endocr. Rev. 18, 774-800 (1997).
28. Maffei, P. et al. Characterization of the IGF system in 15 patients with Alström syndrome. Clin. Endocrinol. 66, 269-275 (2007).
29. Mihai, C. M. et al. Impaired IGF1-GH axis and new therapeutic options in Alström syndrome patients: a case series. Cases J. 2, 19 (2009).
30. Welsh, L. W. Alström syndrome: progressive deafness and blindness. Ann. Otol. Rhinol. Laryngol. 116, 281-285 (2007).
31. Malm, E. et al. Full-field electroretinography and marked variability in clinical phenotype of Alström syndrome. Arch. Ophthalmol. 126, 51-57 (2008).
32. Russell-Eggitt, I. M. et al. Alström syndrome. Report of 22 cases and literature review. Ophthalmology 105, 1274-1280 (1998).
33. van den Abeele, K., Craen, M., Schuil, J. & Meire, F. Ophthalmologic and systemic features of the Alström syndrome: report of 9 cases. Bull. Soc. Belge Ophtalmol. 281, 67-72 (2001).
34. Paisey, R. B. et al. Protection from clinical peripheral sensory neuropathy in Alström syndrome in contrast to early-onset type 2 diabetes. Diabetes Care 32, 462-464 (2009).
35. Hoffman, J. D., Jacobson, Z., Young, T. L., Marshall, J. D. & Kaplan, P. Familial variable expression of dilated cardiomyopathy in Alström syndrome: a report of four sibs. Am. J. Med. Genet. A 135, 96-98 (2005).
36. Worthley, M. I. & Zeitz, C. J. Case of Alström syndrome with late presentation dilated cardiomyopathy. Intern. Med. J. 31, 569-570 (2001).
37. Loudon, M., Bellenger, N., Carey, C. & Paisey, R. Cardiac magnetic resonance imaging in Alström syndrome. Orphanet J. Rare Dis. 4, 14 (2009).
38. Makaryus, A., Zubrow, M., Marshall, J., Gillam, L. & Mangion, J. R. Cardiac manifestations of Alström syndrome: echocardiographie findings. J. Am. Soc. Echocardiogr. 20, 1359-1363 (2007).
39. Smith, J. C. et al. Is arterial stiffening in Alström syndrome linked to the development of cardiomyopathy? Eur. J. Clin. Invest. 37, 99-105 (2007).
40. Goldstein, J. L. & Fialkow, P. J. The Alström syndrome. Report of three cases with further delineation of the clinical, pathophysiological, and genetic aspects of the disorder. Medicine (Baltimore) 52, 53-71 (1973).
41. Özgl, R. K. et al. Molecular analysis and longterm clinical evaluation of three siblings with Alström syndrome. Clin. Genet. 72, 351-356 (2007).
42. Titomanlio, L. et al. Alström syndrome: intrafamilial phenotypic variability in sibs with a novel nonsense mutation of the ALMS1 gene. Clin. Genet. 65, 156-157 (2004).
43. Koç, E. et al. Rare case of Alstrom syndrome without obesity and with short stature, diagnosed in adulthood. Nephrology 11, 81-84 (2006).
44. Collin, G. B., Marshall, J. D., Cardon, L. R. & Nishina, P. M. Homozygosity mapping at Alström syndrome to chromosome 2p. Hum. Mol. Genet. 6, 213-219 (1997).
45. Collin, G. B. et al. Alström syndrome: further evidence for linkage to human chromosome 2p13. Hum. Genet. 105, 474-479 (1999).
46. Macari, F. et al. Refinement of genetic localization of the Alström syndrome on chromosome 2p12-13 by linkage analysis in a North African family. Hum. Genet. 103, 658-661 (1998).
47. Zumsteg, U., Muller, P. Y. & Miserez, A. R. Alstrom syndrome: confirmation of linkage to chromosome 2p12-13 and phenotypic heterogeneity in three affected sibs. J. Med. Genet. 37, E8 (2000).
48. Joy, T. et al. Alstrom syndrome (OMIM 203800): a case report and literature review. Orphanet J. Rare Dis. 2, 49 (2007).
49. Marshall, J. D. et al. Spectrum of ALMS1 variants and evaluation of genotype-phenotype correlations in Alstrom syndrome. Hum. Mutat. 28, 1114-1123 (2007).
50. Bond, J. et al. The importance of seeking ALMS1 mutations in infants with dilated cardiomyopathy. J. Med. Genet. 42, e10 (2005).
51. t Hart, L. M., Maassen, J. A., Dekker, J. M. & Heine, R. J. Lack of association between gene variants in the ALMS1 gene and type 2 diabetes mellitus. Diabetologia 46, 1023-1024 (2003).
52. Patel, S. et al. Common variations in the ALMS1 gene do not contribute to susceptibility to type 2 diabetes in a large white UK population. Diabetologia 49, 1209-1213 (2006).
53. Collin, G. B. et al. Mutations in ALMS1 cause obesity, type 2 diabetes and neurosensory degeneration in Alström syndrome. Nat. Genet. 31, 74-78 (2002).
54. Badano, J. L., Teslovich, T. M. & Katsanis, N. The centrosome in human genetic disease. Nat. Rev. Genet. 6, 194-205 (2005).
55. Davenport, J. R. & Yoder, B. K. An incredible decade for the primary cilium: a look at a onceforgotten organelle. Am. J. Physiol. Renal Physiol. 289, F1159-F1169 (2005).
56. Fliegauf, M., Benzing, T. & Omran, H. When cilia go bad: cilia defects and ciliopathies. Nat. Rev. Mol. Cell Biol. 8, 880-893 (2007).
57. Dawe, H. R., Farr, H. & Gull, K. Centriole/basal body morphogenesis and migration during ciliogenesis in animal cells. J. Cell Sci. 120, 7-15 (2007).
58. Toriello, H. v. & Parisi, M. A. Cilia and the ciliopathies: an introduction. Am. J. Med. Genet. C Semin. Med. Genet. 151c, 261-262 (2009).
59. Lucker, B. F. et al. Characterization of the intraflagellar transport complex B core. J. Biol. Chem. 280, 27688-27696 (2005).
60. Rosenbaum, J. L. & Witman, G. B. Intraflagellar transport. Nat. Rev. Mol. Cell Biol. 3, 813-825 (2002).
61. Leroux, M. R. Taking vesicular transport to the cilium. Cell 129, 1041-1043 (2007).
62. Yen, H.-J. et al. Bardet-Biedl syndrome genes are important in retrograde intracellular trafficking and Kupffers vesicle cilia function. Hum. Mol. Genet. 15, 667-677 (2006).
63. Simpson, F., Kerr, M. C. & Wicking, C. Trafficking, development and hedgehog. Mech. Dev. 126, 279-288 (2009).
64. Zaghloul, N. A. & Katsanis, N. Mechanistic insights into Bardet-Biedl syndrome, a model ciliopathy. J. Clin. Invest. 119, 428-437 (2009).
65. Deane, J. A. & Ricardo, S. D. Polycystic kidney disease and the renal cilium. Nephrology 12, 559-564 (2007).
66. Praetorius, H. A. & Spring, K. R. The renal cell primary cilium functions as a flow sensor. Curr. Opin. Nephrol. Hypertens. 12, 517-520 (2003).
67. Davis, E. E., Brueckner, M. & Katsanis, N. The emerging complexity of the vertebrate cilium: new functional roles for an ancient organelle. Dev. Cell 11, 9-19 (2006).
68. Gerdes, J. M., Davis, E. E. & Katsanis, N. The vertebrate primary cilium in development, homeostasis, and disease. Cell 137, 32-45 (2009).
69. Michaud, E. J. & Yoder, B. K. The primary cilium in cell signaling and cancer. Cancer Res. 66, 6463-6467 (2006).
70. Singla, v. & Reiter, J. F. The primary cilium as the cells antenna: signaling at a sensory organelle. Science 313, 629-633 (2006).
71. Baldari, C. T. & Rosenbaum, J. Intraflagellar transport: its not just for cilia anymore. Curr. Opin. Cell Biol. 22, 75-80 (2009).
72. Liu, Q. et al. The proteome of the mouse photoreceptor sensory cilium complex. Mol. Cell. Proteomics 6, 1299-1317 (2007).
73. Gherman, A., Davis, E. E. & Katsanis, N. The ciliary proteome database: an integrated community resource for the genetic and functional dissection of cilia. Nat. Genet. 38, 961-962 (2006).
74. Inglis, P. N., Boroevich, K. A. & Leroux, M. R. Piecing together a ciliome. Trends Genet. 22, 491-500 (2006).
75. Arsov, T. et al. Fat aussie: a new Alström syndrome mouse showing a critical role for ALMS1 in obesity, diabetes, and spermatogenesis. Mol. Endocrinol. 20, 1610-1622 (2006).
76. Arsov, T. et al. Adaptive failure to high-fat diet characterizes steatohepatitis in Alms1 mutant mice. Biochem. Biophys. Res. Commun. 342, 1152-1159 (2006).
77. Davis, R. E. et al. A knockin mouse model of the Bardet-Biedl syndrome 1 M390R mutation has cilia defects, ventriculomegaly, retinopathy, and obesity. Proc. Natl Acad. Sci. USA 104, 19422-19427 (2007).
78. Rahmouni, K. et al. Leptin resistance contributes to obesity and hypertension in mouse models of Bardet-Biedl syndrome. J. Clin. Invest. 118, 1458-1467 (2008).
79. Coll, A. P., Farooqi, I. S. & ORahilly, S. The hormonal control of food intake. Cell 129, 251-262 (2007).
80. Ellacott, K. L. & Cone, R. D. The central melanocortin system and the integration of short- and long-term regulators of energy homeostasis. Recent Prog. Horm. Res. 59, 395-408 (2004).
81. Schwartz, M. W., Woods, S. C., Porte, D. Jr, Seeley, R. J. & Baskin, D. G. Central nervous system control of food intake. Nature 404, 661-671 (2000).
82. Collin, G. B. et al. Alms1-disrupted mice recapitulate human Alström syndrome. Hum. Mol. Genet. 14, 2323-2333 (2005).
83. Moritz, O. L. et al. Mutant rab8 impairs docking and fusion of rhodopsin-bearing post-golgi membranes and causes cell death of transgenic Xenopus rods. Mol. Biol. Cell 12, 2341-2351 (2001).
84. Larter, C. Z. et al. Roles of adipose restriction and metabolic factors in progression of steatosis to steatohepatitis in obese, diabetic mice. J. Gastroenterol. Hepatol. 24, 1658-1668 (2009).
85. Bratanova-Tochkova, T. K. et al. Triggering and augmentation mechanisms, granule pools, and biphasic insulin secretion. Diabetes 51 (Suppl. 1), S83-S90 (2002).
86. Seo, S. et al. Requirement of Bardet-Biedl syndrome proteins for leptin receptor signaling. Hum. Mol. Genet. 18, 1323-1331 (2009).
87. Davenport, J. R. et al. Disruption of intraflagellar transport in adult mice leads to obesity and slow-onset cystic kidney disease. Curr. Biol. 17, 1586-1594 (2007).
88. Satir, P. Cilia biology: stop overeating now! Curr. Biol. 17, R963-R965 (2007).
89. Berbari, N. F., Bishop, G. A., Askwith, C. C., Lewis, J. S. & Mykytyn, K. Hippocampal neurons possess primary cilia in culture. J. Neurosci. Res. 85, 1095-1100 (2007).
90. Fuchs, J. L. & Schwark, H. D. Neuronal primary cilia: a review. Cell Biol. Int. 28, 111-118 (2004).
91. Whitfield, J. F. The neuronal primary cilium-an extrasynaptic signaling device. Cell. Signal. 16, 763-767 (2004).
92. Sen Gupta, P., Prodromou, N. v. & Chapple, J. P. Can faulty antennae increase adiposity? The link between cilia proteins and obesity. J. Endocrinol. 203, 327-336 (2009).
93. Mok, C. A., Héon, E. & Zhen, M. Ciliary dysfunction and obesity. Clin. Genet. 77, 18-27 (2009).
94. Li, G. et al. A role for Alström syndrome protein, Alms1, in kidney ciliogenesis and cellular quiescence. PLoS Genet. 3, e8 (2007).
95. Nogales-Cadenas, R., Abascal, F., Díez-Pérez, J., Carazo, J. M. & Pascual-Montano, A. CentrosomeDB: a human centrosomal proteins database. Nucleic Acids Res. 37, D175-D180 (2009).
96. Arnaiz, O. et al. Cildb: a knowledgebase for centrosomes and cilia. Database 2009, bap022 (2009).
97. Nachury, M. v. et al. A core complex of BBS proteins cooperates with the GTPase Rab8 to promote ciliary membrane biogenesis. Cell 129, 1201-1213 (2007).
98. Finetti, F. et al. Intraflagellar transport is required for polarized recycling of the TCR/CD3 complex to the immune synapse. Nat. Cell Biol. 11, 1332-1339 (2009).
99. Berbari, N. F., Lewis, J. S., Bishop, G. A., Askwith, C. C. & Mykytyn, K. Bardet-Biedl syndrome proteins are required for the localization of G protein-coupled receptors to primary cilia. Proc. Natl Acad. Sci. USA 105, 4242-4246 (2008).
100. Brailov, I. et al. Localization of 5-HT(6) receptors at the plasma membrane of neuronal cilia in the rat brain. Brain Res. 872, 271-275 (2000).
101. Händel, M. et al. Selective targeting of somatostatin receptor 3 to neuronal cilia. Neuroscience 89, 909-926 (1999).
102. Pazour, G. J. & Witman, G. B. The vertebrate primary cilium is a sensory organelle. Curr. Opin. Cell Biol. 15, 105-110 (2003).
103. Stanic, D. et al. Developmental changes in frequency of the ciliary somatostatin receptor 3 protein. Brain Res. 1249, 101-112 (2009).
104. Chen, Y. et al. Targeted disruption of the melaninconcentrating hormone receptor-1 results in hyperphagia and resistance to diet-induced obesity. Endocrinology 143, 2469-2477 (2002).
105. Praetorius, H. A., Praetorius, J., Nielsen, S., Frokiaer, J. & Spring, K. R. β1-Integrins in the primary cilium of MDCK cells potentiate fibronectin-induced Ca2+ signaling. Am. J. Physiol. Renal Physiol. 287, F969-F978 (2004).
106. Raychowdhury, M. K. et al. vasopressin receptormediated functional signaling pathway in primary cilia of renal epithelial cells. Am. J. Physiol. Renal Physiol. 296, F87-F97 (2009).
107. Marley, A. & von Zastrow, M. DISC1 regulates primary cilia that display specific dopamine receptors. PLoS ONE 5, e10902 (2010).
108. Zhu, D., Shi, S., Wang, H. & Liao, K. Growth arrest induces primary-cilium formation and sensitizes IGF-1-receptor signaling during differentiation induction of 3T3-L1 preadipocytes. J. Cell Sci. 122, 2760-2768 (2009).
109. Marion, v. et al. Transient ciliogenesis involving Bardet-Biedl syndrome proteins is a fundamental characteristic of adipogenic differentiation. Proc. Natl Acad. Sci. USA 106, 1820-1825 (2009).
110. Romano, S. et al. Regulation of Alström syndrome gene expression during adipogenesis and its relationship with fat cell insulin sensitivity. Int. J. Mol. Med. 21, 731-736 (2008).
111. Huang-Doran, I. & Semple, R. K. Knockdown of the Alström syndrome-associated gene Alms1 in 3T3-L1 preadipocytes impairs adipogenesis but has no effect on cell-autonomous insulin action. Int. J. Obes. 34, 1554-1558 (2010).
112. Graser, S. et al. Cep164, a novel centriole appendage protein required for primary cilium formation. J. Cell Biol. 179, 321-330 (2007).
113. Purvis, T. L. et al. Transcriptional regulation of the Alström syndrome gene ALMS1 by members of the RFX family and Sp1. Gene 460, 20-29 (2010).
114. Bonnafe, E. et al. The transcription factor RFX3 directs nodal cilium development and left-right asymmetry specification. Mol. Cell. Biol. 24, 4417-4427 (2004).
115. Essner, J. J. et al. Conserved function for embryonic nodal cilia. Nature 418, 37-38 (2002).
116. Nonaka, S., Shiratori, H., Saijoh, Y. & Hamada, H. Determination of left-right patterning of the mouse embryo by artificial nodal flow. Nature 418, 96-99 (2002).
117. Nonaka, S. et al. Randomization of left-right asymmetry due to loss of nodal cilia generating leftward flow of extraembryonic fluid in mice lacking KIF3B motor protein. Cell 95, 829-837 (1998).
118. Benso, C., Hadjadj, E., Conrath, J. & Denis, D. Three new cases of Alström syndrome. Graefes Arch. Clin. Exp. Ophthalmol. 240, 622-627 (2002).
119. Sinha, S. et al. Effect of metformin and rosiglitazone in a prepubertal boy with Alström syndrome. J. Pediatr. Endocrinol. Metab. 20, 1045-1052 (2007).
120. Paisey, R. B. New insights and therapies for the metabolic consequences of Alström syndrome. Curr. Opin. Lipidol. 20, 315-320 (2009).
121. Holder, M., Hecker, W. & Gilli, G. Impaired glucose tolerance leads to delayed diagnosis of Alström syndrome. Diabetes Care 18, 698-700 (1995).
122. Lee, N.-C. et al. Caloric restriction in Alström syndrome prevents hyperinsulinemia. Am. J. Med. Genet. A 149A, 666-668 (2009).
123. Mihai, C., Catrinoiu, D., Marshall, J., Stoicescu, R. & Tofolean, I. Cilia, Alström syndrome-molecular mechanisms and therapeutic perspectives. J. Med. Life 1, 254-261 (2008).
124. Tai, T. S., Lin, S. Y. & Sheu, W. H. Metabolic effects of growth hormone therapy in an Alström syndrome patient. Horm. Res. 60, 297-301 (2003).
125. Goerler, H. et al. Heart-lung transplantation in a 14-year-old boy with Alström syndrome. J. Heart Lung Transplant. 26, 1217-1218 (2007).
126. Hitz, M.-P. et al. Levosimendan for bridging in a pediatric patient with Alström syndrome awaiting heart-lung transplantation. Clin. Res. Cardiol. 97, 846-848 (2008).
127. Alström Syndrome International [online], http://www.alstrom.org/ (2010).
128. Alström Syndrome UK [online], http://www.alstrom.org.uk/ (2010).